In the evolving landscape of pharmaceutical intermediates, Kanda Bilirubin stands as a cornerstone for metabolic research and diagnostic reagent formulation. Our commitment to excellence begins at the molecular level, leveraging advanced biosynthetic pathways to ensure high purity and consistent performance.
Our production protocols utilize state-of-the-art crystallization and chromatography techniques to achieve Kanda Bilirubin standards that meet international USP/EP pharmacological benchmarks.
By integrating IoT-enabled monitoring and automated synthesis, our production facilities represent the pinnacle of China’s Industry 4.0 transformation, ensuring supply chain resilience and minimal batch-to-batch variance.
We provide full documentation support, including DMF filings, REACH compliance, and ISO certifications, facilitating seamless entry into US, EU, and Asian markets.
Chengdu ChenLv Herb Co., Ltd. (Chenlv Herb) continues to bridge the gap between ancient botanical wisdom and modern pharmaceutical science. Our integrated approach ensures that every gram of extract—whether Kanda Bilirubin or specialized plant derivatives—undergoes rigorous quality assurance.
Integrated research, manufacturing, and R&D excellence.
We utilize high-performance liquid chromatography (HPLC) and NMR spectroscopy to verify molecular structure and purity levels. Each batch comes with a detailed Certificate of Analysis (COA) to ensure transparency.
Since 2012, we have focused on a "homology of medicine and food" philosophy, combined with industrialized, large-scale extraction capabilities, allowing us to serve global pharma giants with consistent quality.
Chenlv Herb
